🔎 Trials Near Me

Home › Kanser sa Dugo › Alabama

Pag-aaral pangklinika para sa Kanser sa Dugo sa Alabama

11 pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa mga site sa Alabama.

Mga Lungsod sa Alabama

Opisyal na teksto ng pag-aaral (English)

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

  • University of Alabama Birmingham, Birmingham
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04634552

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 16, Birmingham
Nagre-recruitPhase 3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07504458

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Alabama at Birmingham, Birmingham
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

  • Children's Hospital of Alabama, Birmingham
Nagre-recruitPhase 3
Edad 2 hanggang 18 · Lahat ng kasarian · Na-update May 5, 2026 · NCT05711667

Cognitive Training Intervention and Attitudes Towards Genetics

  • University of Alabama at Birmingham, Birmingham
Nagre-recruit
Edad 21 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT03094026

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

  • University of Alabama at Birmingham, Birmingham
Nagre-recruitPhase 1
4 Weeks – 75 Years · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06047886

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

  • University of Alabama at Birmingham, Birmingham
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT07044544

Diet and Cognitive Training in Hematologic Cancer Survivors

  • University of Alabama at Birmingham, Birmingham
Nagre-recruit
Edad 21 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT05708716

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

  • University of Alabama at Brimingham, Birmingham
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2025 · NCT06472089

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • University of Alabama at Birmingham, Birmingham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.